Welcome to our dedicated page for Trilogy Metals SEC filings (Ticker: TMQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trilogy Metals Inc. filings document formal disclosures for a British Columbia mineral exploration issuer focused on the Upper Kobuk Mineral Projects in Alaska. Recent Form 8-K reports furnish operating and financial results, Regulation FD project updates, permitting-related announcements, district land-use developments, and Ambler Metals LLC joint-venture leadership information.
The company's proxy materials disclose annual meeting business, director elections, auditor appointment, executive compensation votes, and governance procedures. Filing themes also include financing and capital-structure disclosure, project context, and the securities-law treatment of furnished press-release exhibits.
Trilogy Metals’ major shareholder group filed an amended Schedule 13D reporting beneficial ownership of 31,604,741 common shares, or 18.5% of the company. The Electrum Strategic Opportunities Fund L.P., its general partner ESOF GP Ltd., The Electrum Group LLC and Thomas S. Kaplan each report shared voting and investment power over these shares, which are held by ESOF. The ownership percentage is based on 171,059,888 common shares outstanding as of November 6, 2025.
The amendment also reports that on December 26, 2025, common shares previously held by GRAT Holdings LLC, Tigris Financial Group Ltd. and Kaplan were transferred to accounts for the benefit of Kaplan or his spouse and then donated to a charitable foundation for no consideration. As a result, GRAT Holdings now reports beneficial ownership of zero Trilogy Metals shares and has ceased to be a beneficial owner.
Trilogy Metals Inc. furnished a press release outlining the 2026 program and budget for Ambler Metals LLC, along with its own corporate budget for 2026. The press release, dated December 17, 2025, is included as Exhibit 99.1 to the report and is provided under a Regulation FD disclosure, meaning it is treated as furnished rather than filed for certain liability purposes. Trilogy Metals’ common shares trade on the NYSE American and the Toronto Stock Exchange under the symbol TMQ.
Trilogy Metals Inc. reported insider equity transactions by its VP & CFO on a Form 4 for December 11, 2025. The executive acquired 15,000 common shares through the settlement of restricted stock units and now directly owns 3,347,895 common shares.
The filing also shows a grant of an employee stock option for 260,000 common shares with an exercise price of $4.61 per share and an expiration date of December 10, 2030. These options vest in three equal installments on December 11, 2025, 2026, and 2027. In addition, the executive received 45,000 restricted stock units (RSUs), which vest on the same schedule, and holds 30,000 RSUs after 15,000 RSUs were converted into common shares.
Trilogy Metals Inc. insider Tony Giardini, who serves as President, CEO and Director, reported multiple equity transactions dated December 11, 2025. He acquired 60,000 common shares through the settlement of restricted stock units, bringing his directly held beneficial ownership to 8,758,728 common shares following the transactions.
He was also granted an employee stock option for 360,000 common shares at an exercise price of $4.61 per share, expiring on December 10, 2030. These options vest in three equal installments on December 11, 2025, December 11, 2026, and December 11, 2027. In addition, he received 180,000 restricted stock units, which vest in three equal tranches on December 7, 2023, December 7, 2024, and December 7, 2025.
Trilogy Metals Inc. director Diana J. Walters reported receiving a director stock option on December 11, 2025. The option covers 50,000 common shares of Trilogy Metals at an exercise price of $4.61 per share, described as converted from a Canadian exercise price of C$6.35 using an exchange rate of C$1.3774 = US$1.00. The option is exercisable starting on December 11, 2025 and expires on December 10, 2030. Following this grant, Walters beneficially owns 50,000 derivative securities directly.
Trilogy Metals Inc. reported a new stock option grant to a director. On 12/11/2025, the director received a Director Stock Option covering 65,000 common shares at an exercise price of $4.61 per share. The options become exercisable on 12/11/2025 and expire on 12/10/2030, giving the holder the right to buy Trilogy Metals common shares at this fixed price during that period.
The exercise price of $4.61 was derived from a Canadian exercise price of C$6.35 using an exchange rate of C$1.3774 = US$1.00. After this grant, the reporting person beneficially owns 65,000 derivative securities, all held directly. This filing reflects routine equity-based compensation for board service rather than a sale or purchase of existing shares.
Trilogy Metals Inc. reported a director equity award on a Form 4. On 12/11/2025, the director received a stock option to buy 50,000 common shares of Trilogy Metals.
The option has an exercise price of $4.61 per share, which was converted from a Canadian exercise price of C$6.35 using an exchange rate of C$1.3774 = US$1.00. The option is exercisable starting 12/11/2025 and expires on 12/10/2030. Following this grant, the director beneficially owns 50,000 derivative securities directly.
Trilogy Metals Inc. director William I. Iggiagruk Hensley reported a stock option grant. On 12/11/2025, he received a director stock option to buy 50,000 common shares of Trilogy Metals at an exercise price of $4.61 per share. The option becomes exercisable on 12/11/2025 and expires on 12/10/2030, giving a five-year window to exercise once it is vested. The U.S. dollar exercise price was calculated from a Canadian dollar exercise price of C$6.35 using an exchange rate of C$1.3774 = US$1.00.
Trilogy Metals Inc. reported a director stock option grant for William Beckwith Hayden. On 12/11/2025, he was awarded options to buy 50,000 common shares of Trilogy Metals.
The options have an exercise price of $4.61 per share, which was converted from a Canadian exercise price of C$6.35 using an exchange rate of C$1.3774 = US$1.00. The options become exercisable on 12/11/2025 and expire on 12/10/2030. After this grant, he beneficially owns 50,000 derivative securities directly.
Trilogy Metals Inc. (TMQ) reported an insider equity award for director James Gowans. On 12/11/2025, he received a director stock option covering 50,000 common shares at an exercise price of $4.61 per share. The option is exercisable starting 12/11/2025 and expires on 12/10/2030.
The exercise price was converted from a Canadian exercise price of C$6.35 using an exchange rate of C$1.3774 = US$1.00, so the award is valued and reported in U.S. dollars for disclosure purposes.